EMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Eastman Chemical Co (EMN) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While there are some positive indicators, such as hedge fund buying and a slight upward trend in price, the company's weak financial performance, lack of recent positive news, and mixed analyst ratings suggest that it is better to hold off on purchasing this stock until clearer signs of recovery or growth emerge.
The MACD is positive and expanding, suggesting a bullish momentum. RSI is neutral at 64.094, indicating no overbought or oversold conditions. Moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R2: 73.831), which may act as a ceiling for further price increases in the short term.
Hedge funds are significantly increasing their positions, with a 626.44% rise in buying activity over the last quarter. Analysts from Citi and BofA maintain a Buy rating with price targets above the current price, suggesting some long-term upside potential.
The company's Q4 2025 financials show a significant decline in revenue (-12.12% YoY), net income (-68.18% YoY), and EPS (-67.49% YoY). Gross margin also dropped by 30.59%. Analysts have mixed ratings, with some expressing concerns about cyclical softness and limited organic growth opportunities. No recent news or congress trading activity to act as a positive catalyst.
In Q4 2025, Eastman Chemical reported a sharp decline in revenue, net income, and EPS, reflecting ongoing cyclical challenges. The gross margin also dropped significantly, indicating operational inefficiencies or pricing pressures.
Analyst ratings are mixed. Citi and BofA are bullish with Buy ratings and price targets of $84 and $79, respectively. However, other firms like RBC and Fermium Research express concerns about cyclical softness and limited growth opportunities, maintaining Sector Perform or Hold ratings.
